Abstract:We have performed docking and molecular dynamics simulations of hydroxamates complexed with human gelatinase-A (MMP-2) to gain insight into the structural and energetic preferences of these inhibitors. The study was conducted on a selected set of eleven compounds with variation in structure and activity. Molecular dynamics simulations were performed at 300 K for 100 ps with equilibration for 50 ps. The structural analyses of the trajectories indicate that the coordinate bond interactions, the hydrogen bond interactions, the van der Waals interactions as well as the hydrophobic interactions between ligand and receptor are responsible simultaneously for the preference of inhibition and potency. The ligand hydroxamate group is coordinated to the catalytic zinc ion and form stable hydrogen bonds with the carbonyl oxygen of Gly 162. The P1′ group makes extensive van der Waals and hydrophobic contacts with the nonpolar side chains of several residues in the S1′ subsite, including Leu 197, Val 198, Leu 218 and Tyr 223. Moreover, four to eight hydrogen bonds between hydroxamates and MMP-2 are formed to stabilize the inhibitors in the active site. Compared with the P2′ and P3′ groups, the P1′ groups of inhibitors are oriented regularly, which is produced by the restrain of the S1′ subsite. From the relationship between the length of the nonpolar P1′ group and the biological activity, we confirm that MMP-2 has a pocket-like S1′ subsite, not a channel-like S1′ subsite proposed by Kiyama (Kiyama, R. et al., J. Med. Chem. 42 (1999), 1723). The energetic analyses show that the experimental binding free energies can be well correlated with the interactions between the inhibitors and their environments, which could be used as a simple score function to evaluate the binding affinities for other similar hydroxamates. The validity of the force field parameters and the MD simulations can be fully testified by the satisfactory agreements between the experimental structure-activity relationship and the information from the structural and energetic analyses. The information generated from the predicted complexes should be useful for further work in the area of structure-based design of new compounds.

Molecular Docking and Molecular Dynamics Simulations of Inhibitors Binding to Jack Bean Urease

Synthesis, Molecular Docking and Biological Evaluation of Schiff Base Transition Metal Complexes As Potential Urease Inhibitors

Molecular docking and molecular dynamic simulations of inhibitor ZJ0777 and CIE binding to acetohydroxyacid synthases

Synthesis, Crystal Structures, Molecular Docking and Urease Inhibitory Activity of Nickel(ii) Complexes with 3-Pyridinyl-4-amino-5-mercapto-1,2,4-triazole

Molecular Docking and Molecular Dynamics Simulations of the Urease Inhibitory Activity of 2,3‐Dihydroxybenzohydrazide Derivatives

ComABAN: refining molecular representation with the graph attention mechanism to accelerate drug discovery

Synthesis and Biological Evaluation of Cu(Ii), Zn(Ii), and Ni(Ii) 3-(4-nitrophenyl)acrylic Acid Complexes with Diamines As Potential Urease Inhibitors

A Comprehensive Analysis through Molecular Docking and Molecular Dynamics Simulation

Synthesis, structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

Unraveling Binding Mechanism and Stability of Urease Inhibitors: A QM/MM MD Study

Synthesis, Structures and Urease Inhibition Studies of Copper(ii) and Nickel(ii) Complexes with Bidentate N,O-donor Schiff Base Ligands.

Synthesis, Crystal Structures, Molecular Docking, and in Vitro Biological Activities Evaluation of Transition Metal Complexes with 4-(3,4-dichlorophenyl) Piperazine-1-Carboxylic Acid

Unveiling the Novel Characteristics of IGPD Polymer and Inhibitors Binding Affinities Using 12-6-4 LJ-type Nonbonded Mn2+ Model

Molecular docking study on interaction mode between yeast AHAS and sulfonylureas inhibitors

Syntheses, Structures and Urease Inhibitory Activities of Mononuclear Cobalt(iii) and 1D Cobalt(ii) Complexes with Ligands Derived from 3-Formylsalicylic Acid

Synthesis, Crystal Structure, and Urease Inhibition Studies of Copper(Ii) and Cobalt(Iii) Complexes with Bi(2-Fluorobenzylaminoethyl)Amine

Molecular docking studies of a group of hydroxamate inhibitors with gelatinase-A by molecular dynamics

Transition Metal Complexes (m=cu, Ni and Mn) of Schiff-base Ligands: Syntheses, Crystal Structures, and Inhibitory Bioactivities Against Urease and Xanthine Oxidase

Molecular docking and molecular dynamics simulation analyses of urea with ammoniated and ammoxidized lignin

Using Machine Learning and Molecular Docking to Leverage Urease Inhibition Data for Virtual Screening

Comparative analysis of Zn(II)-Complexes as model metalloenzyme for mimicking Jack Bean Urease